Skip to main content

General AI News

Machine learning-driven drug repurposing for HER2-positive breast cancer

By Basavana Gowda Hosur Dinesh, Srinivas Ganjipete, Bandral Sunil Kumar, Damodar Nayak Ammunje, Selvaraj Kunjiappan, Prabu Kumar Seetharaman, Mohankumar Ramar, Kumarappan Chidambaram, Parasuraman Pavadai Source: Nature.com
Machine learning-driven drug repurposing for HER2-positive breast cancer

Researchers have used machine learning algorithms to identify existing drugs that could be repurposed to treat HER2-positive breast cancer, potentially accelerating treatment options for patients. The study leverages bioinformatics approaches and computational analysis to screen drug candidates more efficiently than traditional methods. This drug repurposing strategy could reduce development time and costs while offering new therapeutic alternatives for this aggressive form of breast cancer.

Read Full Article at Nature.com

Related Articles